Clinical trial
Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
NCT00561587 is registered in ClinicalTrials.gov with Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
- Lead sponsor
- Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- February 28, 2010
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol abuse, alcohol consumption, alcohol drinking, alcohol relapse prevention, alcoholism